IL96311A - Medications with delayed release - Google Patents

Medications with delayed release

Info

Publication number
IL96311A
IL96311A IL9631190A IL9631190A IL96311A IL 96311 A IL96311 A IL 96311A IL 9631190 A IL9631190 A IL 9631190A IL 9631190 A IL9631190 A IL 9631190A IL 96311 A IL96311 A IL 96311A
Authority
IL
Israel
Prior art keywords
weight percent
drug
sustained
granules
drug dosage
Prior art date
Application number
IL9631190A
Other languages
English (en)
Hebrew (he)
Other versions
IL96311A0 (en
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27033923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL96311(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL96311A0 publication Critical patent/IL96311A0/xx
Publication of IL96311A publication Critical patent/IL96311A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL9631190A 1989-12-01 1990-11-12 Medications with delayed release IL96311A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44445889A 1989-12-01 1989-12-01
US60515290A 1990-11-02 1990-11-02

Publications (2)

Publication Number Publication Date
IL96311A0 IL96311A0 (en) 1991-08-16
IL96311A true IL96311A (en) 1995-05-26

Family

ID=27033923

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9631190A IL96311A (en) 1989-12-01 1990-11-12 Medications with delayed release

Country Status (13)

Country Link
EP (1) EP0430287B2 (de)
JP (1) JP3010562B2 (de)
KR (1) KR100223131B1 (de)
AT (1) ATE112678T1 (de)
AU (1) AU623560B2 (de)
CA (1) CA2031150C (de)
DE (1) DE69013296T3 (de)
DK (1) DK0430287T4 (de)
ES (1) ES2065461T5 (de)
GR (1) GR3034483T3 (de)
IE (1) IE66116B1 (de)
IL (1) IL96311A (de)
PT (1) PT96046B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4127665A1 (de) * 1991-08-22 1993-02-25 Beiersdorf Ag Galenische matrix
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
KR100354702B1 (ko) 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
US6395303B1 (en) 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US6936277B2 (en) 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US6391337B2 (en) 1995-11-15 2002-05-21 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6852336B2 (en) 1995-11-15 2005-02-08 J. Rettenmaier & Soehne Gmbh + Co. Kg Directly compressible high load acetaminophen formulations
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
JP3611456B2 (ja) * 1997-09-30 2005-01-19 日研化学株式会社 テオフィリン徐放性錠剤
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
WO2000037055A1 (en) * 1998-12-18 2000-06-29 Abbott Laboratories Controlled release formulation of divalproex sodium
US6713086B2 (en) 1998-12-18 2004-03-30 Abbott Laboratories Controlled release formulation of divalproex sodium
US6511678B2 (en) 1998-12-18 2003-01-28 Abbott Laboratories Controlled release formulation of divalproex sodium
US6528090B2 (en) 1998-12-18 2003-03-04 Abbott Laboratories Controlled release formulation of divalproex sodium
US6419953B1 (en) 1998-12-18 2002-07-16 Abbott Laboratories Controlled release formulation of divalproex sodium
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
KR101476574B1 (ko) 1999-10-29 2014-12-24 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
MXPA03003895A (es) 2000-10-30 2003-07-28 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada.
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
EP1591109B1 (de) * 2004-04-30 2008-07-02 TopoTarget Germany AG Histondeacetylase-Inhibitor enthaltende Formulierung zur zweiphasigen Freisetzung
DE102004035938A1 (de) * 2004-07-23 2006-02-16 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen mit stabilem Wirkstofffreigabeprofil
KR100806541B1 (ko) * 2005-05-11 2008-02-26 한국유나이티드제약 주식회사 아세클로페낙을 함유하는 제어 방출성 제제
US20100172982A1 (en) * 2007-05-23 2010-07-08 Sun Pharmaceutical Industries Limited Sustained release formulations of divalproex sodium
EP2030613A1 (de) * 2007-08-17 2009-03-04 Abbott GmbH & Co. KG Herstellung von Zusammensetzungen mit hauptsächlich nichtkristallinen eingebetteten Makrolid-Antibiotika

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963451A (en) † 1973-02-15 1976-06-15 United States Steel Corporation Method of forming a high-temperature abrasion-resistant coating on a ferrous metal substrate, and resulting article
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
FI63335B (fi) † 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
DK150008C (da) † 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
GB2186485B (en) † 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
IE63242B1 (en) * 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom

Also Published As

Publication number Publication date
EP0430287A3 (en) 1991-08-21
IE904091A1 (en) 1991-06-05
IE66116B1 (en) 1995-12-13
AU6764390A (en) 1991-02-14
IL96311A0 (en) 1991-08-16
ATE112678T1 (de) 1994-10-15
EP0430287B2 (de) 2000-07-12
DK0430287T3 (da) 1995-02-27
KR100223131B1 (ko) 1999-10-15
CA2031150A1 (en) 1991-06-02
DK0430287T4 (da) 2000-10-02
EP0430287B1 (de) 1994-10-12
JPH03190817A (ja) 1991-08-20
EP0430287A2 (de) 1991-06-05
DE69013296T3 (de) 2000-11-09
AU623560B2 (en) 1992-05-14
ES2065461T5 (es) 2001-01-01
PT96046A (pt) 1991-09-13
KR910011243A (ko) 1991-08-07
GR3034483T3 (en) 2000-12-29
PT96046B (pt) 2001-09-27
DE69013296D1 (de) 1994-11-17
CA2031150C (en) 2000-11-21
DE69013296T2 (de) 1995-02-23
ES2065461T3 (es) 1995-02-16
JP3010562B2 (ja) 2000-02-21

Similar Documents

Publication Publication Date Title
EP0430287B2 (de) Einzeldosen mit verzögerter Arzneistofffreigabe
US5169642A (en) Sustained-release drug dosage units
US5902632A (en) Method of preparation of controlled release nifedipine formulations
US5268182A (en) Sustained-release drug dosage units of terazosin
US6312728B1 (en) Sustained release pharmaceutical preparation
US4673564A (en) Sustained release pharmaceutical composition of solid medical material
CA1315202C (en) Oral sustained release acetaminophen formulation and process
RU2136283C1 (ru) Препарат с контролируемым высвобождением лекарства и способ его получения, способ лечения
US5405619A (en) Controlled release therapeutic system for liquid pharmaceutical formulations
US5320853A (en) Controlled release formulation for pharmaceutical compounds
US4814175A (en) Nifedipine combination preparation
NZ201008A (en) Oral preparations containing dipyridamole and at least 5 molar equivalents of orally acceptable acidic excipient
IE58967B1 (en) New drug preparation
WO1997004752A1 (en) Pharmaceutical compositions of conjugated estrogens and methods for their use
EP0148811A1 (de) Pharmazeutische Komposition
US4859469A (en) Novel galenic forms of verapamil, their preparation and medicines containing said novel galenic forms
GB2204241A (en) Fat coated pharmaceutical compositions
CS396391A3 (en) Theophyline-containing retarded preparation
US8535716B2 (en) Methods and composition of extended delivery of water insoluble drugs
US4938966A (en) Controlled release flecainide acetate formulation
CZ146494A3 (en) Ipsapirone healing preparation
CA1293449C (en) Controlled release drug preparation

Legal Events

Date Code Title Description
CB Opposition filed against grant of patent

Free format text: 24.08.95

KB Patent renewed
CB Opposition filed against grant of patent
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees